title: Psoriasiform mycosis fungoides with fatal outcome after treatment with cyclosporine.
authors.forename: Herschel S
authors.initials: HS
authors.lastname: Zackheim
authors.forename: John
authors.initials: J
authors.lastname: Koo
authors.forename: Philip E
authors.initials: PE
authors.lastname: LeBoit
authors.forename: Timothy H
authors.initials: TH
authors.lastname: McCalmont
authors.forename: Paul H
authors.initials: PH
authors.lastname: Bowman
authors.forename: Mohammed
authors.initials: M
authors.lastname: Kashani-Sabet
authors.forename: Carol
authors.initials: C
authors.lastname: Jones
authors.forename: James
authors.initials: J
authors.lastname: Zehnder
mesh_terms: D016572:Cyclosporine / Q000009:adverse effects / Q000627:therapeutic use; D003937:Diagnosis, Differential; D017809:Fatal Outcome; D005260:Female; D006801:Humans; D007150:Immunohistochemistry; D008875:Middle Aged; D009182:Mycosis Fungoides / Q000188:drug therapy / Q000473:pathology*; D011565:Psoriasis / Q000188:drug therapy / Q000473:pathology*; D018570:Risk Assessment; D012720:Severity of Illness Index; D012878:Skin Neoplasms / Q000188:drug therapy / Q000473:pathology*
chemical_list: D016572:Cyclosporine